Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01684020 · ClinicalTrials.gov registry record · Phase 2
A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty
A Phase 2 study, sponsored by DeNova Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT01684020 is a Phase 2 study that has completed, run by DeNova Research. The registered enrollment target is 10 participants.
The verdict
NCT01684020, a Phase 2 study, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Rhinoplasty (nasal reconstruction i.e. "a nose job") is a surgical procedure performed on the nose to correct a medical problem or change the appearance of the nose. During the healing process, swelling and/or bruising is likely to occur. A drug called ARTISS Fibrin Sealant may or may not lessen these effects. This study is looking to see the effects of ARTISS on adhering tissue and improving wound healing in an external rhinoplasty. The purpose of this study is to evaluate the safety and effectiveness of rhinoplasty using ARTISS compared to rhinoplasty without using ARTISS in patients undergoing rhinoplasty performed through an external approach.
Interventions
- BIOLOGICAL ARTISS human fibrin sealant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-11-28 |
| Est. Completion | 2016-04-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01684020
The ClinicalTrials.gov registry entry for NCT01684020 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ARTISS human fibrin sealant is the first listed.
NCT01684020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01684020 about?
NCT01684020 is a clinical study titled "A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty". Rhinoplasty (nasal reconstruction i.e. "a nose job") is a surgical procedure performed on the nose to correct a medical problem or change the appearance of the nose. During the healing process, swelling and/or bruising is likely to occur. A drug called ARTISS Fibrin Sealant may or may not lessen the...
What is the current status of trial NCT01684020?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2012-11-28. Estimated completion is 2016-04-26.
What interventions are being tested in trial NCT01684020?
The interventions under investigation include: ARTISS human fibrin sealant (BIOLOGICAL).
Who is sponsoring clinical trial NCT01684020?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.